ShiraTronics' Latest Pilot Study Shows Promising Neuromodulation Therapy for Chronic Migraine Success ShiraTronics has revealed positive 12-month follow-up results from its RELIEV-CM study, highlighting sustained benefits in chronic migraine treatment with an investigational device.

ShiraTronics' Latest Pilot Study Shows Promising Neuromodulation Therapy for Chronic Migraine Success #USA #Minneapolis #ShiraTronics #Migraine_Therapy #RELIEV-CM